Clinical data was reported for the first time in patients receiving an 8 mg dose per injection (Cohort 9 of the dose escalation portion of ...

The global nonprofit WITNESS seeks to address one of the biggest data gaps in the digital verification landscape: the ...

Circle Pharma Announces Poster Presentation Highlighting the Potential of CID-078, a First-in-class Oral Cyclin A/B RxL Inhibitor, at the American Association for Cancer Research Special Conference on ...

Cyclerion Therapeutics, Inc. ( NASDAQ: CYCN) Pioneering a New Era in Neuropsychiatric Therapies Conference September 24, 2025 10:30 AM EDT ...

SAN FRANCISCO and BOSTON, Sept. 11, 2025 (GLOBE NEWSWIRE) -- Apogee Therapeutics, Inc., (Nasdaq: APGE), a clinical-stage biotechnology company advancing optimized, novel biologics with potential for ...

PALO ALTO, Calif., Sept. 2, 2025 /PRNewswire/ -- Evommune, Inc., a clinical stage biotechnology company discovering and developing innovative therapies that target key drivers of chronic inflammatory ...

Ahead of the 2025 European Society of Retina Specialists (EURETINA) Congress and Retina Society Annual Scientific Meeting, three more companies have announced the presentation of new data.

August 11, 2025 - Previous articles in this series have explored identification, preservation, collection, review and production of novel data sources, but I would be remiss if I left out the last, ...

Today’s enterprises continue to invest aggressively in “cloud-first” strategies and architectures. All industries and verticals are adopting cloud services across all layers of cloud deployment models ...

What Happened: The surge in NextCure’s stock value came after the company presented new preclinical data for NC605, a potential treatment for brittle bone disease. Earlier in the day, the company’s ...

Crinetics Pharmaceuticals, Inc. announced that eight abstracts detailing their clinical development programs will be presented at the Endocrine Society's Annual Meeting, ENDO 2025. The presentations ...